uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 13, 2017

Hi-Tech To Pay Over 40 Million to Settle FTC Charges of False Claims

On October 11, 2017, a U.S. District Judge ruled that Hi-Tech Pharmaceuticals Inc. violated permanent legal injunctions disallowing supplement distributors to make unsubstantiated claims about Hi-Tech's weight-loss products, Fastin, Stimerex-ES, Benzedrine, and a reformulated version of Lipodrene. The company printed unfounded advertisements about four of their products, and three individuals, including the CEO Jared Wheat, were found responsible.

Dozens of claims were made on product packaging, on product descriptions online, and in printed advertisements. For example, Lipodrene was advertised as "a revolutionary weight loss formula scientifically engineered to help people lose weight and feel great!" An ad for Fastin stated the "World's Most Advanced Weight Loss Aid Ever Developed!" Benedrine was marketed as "the most potent Fat Burner/Energizer known to man," and Stimerex-ES was supposedly "the Strongest Fat Burner/Energizer to ever hit the market!" 

The company failed to perform any randomized control trials of the products Fastin, Stimerex-ES, Benzedrine, and a reformulated version of Lipodrene to substantiate claims made in advertisements. The $40.1 million in sanctions will be used to reimburse those who purchased any of the products.

See related warnings:

FDA Identifies More Products Listing Synthetic Amphetamine

$2 Million In Weight Loss and "Fat-Burning" Supplements Seized

Sexual Enhancement Supplement Recalled -- Second Time Found with Drug-like Compound

Government Stops Sale of Supplements Claiming to Treat Obesity and Impotence

To read NutraIngredient's complete article about the judgement, use the link below.